Researchers have found that an injection given during some asthma and Chronic Obstructive Pulmonary Disease (COPD) attacks reduces the need for further treatment by 30 per cent, which is more ...
Pharmac has announced that, from January 1 2025, it will fund palivizumab - a medicine that prevents serious illness from respiratory syncytial virus (RSV) in high-risk babies and young children - as ...
RSV season is beginning, but for the first time, parents can access an effective treatment to protect their infants from this common but dangerous virus.